NL990010I2 - Ä3HÜ-imidazo-Ä5,1-dÜ-1,2,3,5-tetrazine-4-one derivatives and pharmaceutical compositions containing these derivatives. - Google Patents

Ä3HÜ-imidazo-Ä5,1-dÜ-1,2,3,5-tetrazine-4-one derivatives and pharmaceutical compositions containing these derivatives.

Info

Publication number
NL990010I2
NL990010I2 NL990010C NL990010C NL990010I2 NL 990010 I2 NL990010 I2 NL 990010I2 NL 990010 C NL990010 C NL 990010C NL 990010 C NL990010 C NL 990010C NL 990010 I2 NL990010 I2 NL 990010I2
Authority
NL
Netherlands
Prior art keywords
derivatives
ä3hü
tetrazine
imidazo
pharmaceutical compositions
Prior art date
Application number
NL990010C
Other languages
Dutch (nl)
Other versions
NL990010I1 (en
Original Assignee
Cancer Res Campaign Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Res Campaign Tech filed Critical Cancer Res Campaign Tech
Publication of NL990010I1 publication Critical patent/NL990010I1/en
Publication of NL990010I2 publication Critical patent/NL990010I2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
NL990010C 1981-08-24 1999-04-01 Ä3HÜ-imidazo-Ä5,1-dÜ-1,2,3,5-tetrazine-4-one derivatives and pharmaceutical compositions containing these derivatives. NL990010I2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8125791 1981-08-24

Publications (2)

Publication Number Publication Date
NL990010I1 NL990010I1 (en) 1999-07-01
NL990010I2 true NL990010I2 (en) 1999-09-01

Family

ID=10524141

Family Applications (2)

Application Number Title Priority Date Filing Date
NL8203286A NL192739C (en) 1981-08-24 1982-08-23 3H-imidazo-5,1-d-1,2,3,5-tetrazine-4-one derivatives and pharmaceutical compositions containing these derivatives.
NL990010C NL990010I2 (en) 1981-08-24 1999-04-01 Ä3HÜ-imidazo-Ä5,1-dÜ-1,2,3,5-tetrazine-4-one derivatives and pharmaceutical compositions containing these derivatives.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NL8203286A NL192739C (en) 1981-08-24 1982-08-23 3H-imidazo-5,1-d-1,2,3,5-tetrazine-4-one derivatives and pharmaceutical compositions containing these derivatives.

Country Status (29)

Country Link
JP (1) JPS5843975A (en)
KR (1) KR890000094B1 (en)
AT (1) AT380256B (en)
AU (1) AU571430B2 (en)
BE (1) BE894175A (en)
CA (1) CA1197247A (en)
CH (1) CH655114A5 (en)
DE (2) DE19975037I2 (en)
DK (1) DK161147C (en)
ES (1) ES8400438A1 (en)
FI (1) FI73434C (en)
FR (1) FR2511679A1 (en)
GB (1) GB2104522B (en)
GE (1) GEP19960641B (en)
GR (1) GR76863B (en)
HU (1) HU186107B (en)
IE (1) IE53408B1 (en)
IL (1) IL66606A (en)
IT (1) IT1152505B (en)
LT (1) LT2436B (en)
LU (1) LU84347A1 (en)
LV (2) LV5511A3 (en)
NL (2) NL192739C (en)
NZ (1) NZ201668A (en)
OA (1) OA07174A (en)
SE (1) SE448543B (en)
SU (1) SU1447284A3 (en)
UA (1) UA5971A1 (en)
ZA (1) ZA826120B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260291A (en) * 1981-08-24 1993-11-09 Cancer Research Campaign Technology Limited Tetrazine derivatives
FR2531958B1 (en) * 1982-08-17 1986-10-31 May & Baker Ltd NEW DERIVATIVES
GB2125402B (en) * 1982-08-17 1985-11-13 May & Baker Ltd New tetrazine derivatives
US4517182A (en) * 1983-05-24 1985-05-14 Warner-Lambert Company 3-(Haloethyl)-4-oxopyrazolo-[5,1-d]-1,2,3,5-tetrazine-8-carboxamide composition
GB8616125D0 (en) * 1986-07-02 1986-08-06 May & Baker Ltd Compositions of matter
AU622330B2 (en) * 1989-06-23 1992-04-02 Takeda Chemical Industries Ltd. Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
EP1706407A2 (en) * 2003-12-30 2006-10-04 Chemagis Ltd. Novel crystalline forms of temozolomide
ES2552338T3 (en) 2005-01-21 2015-11-27 Astex Therapeutics Limited Pharmaceutical compounds
AR060635A1 (en) 2006-04-27 2008-07-02 Banyu Pharma Co Ltd DERIVATIVES OF 1,2-DIHIDRO-3H-PIRAZOLO [3,4-D] PIRIMIDIN-3-ONA, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM AND THEIR USE IN THE TREATMENT OF CANCER
JP2008081492A (en) 2006-08-31 2008-04-10 Banyu Pharmaceut Co Ltd New aminopyridine derivative having aurora a selective inhibitory action
EP2073807A1 (en) 2006-10-12 2009-07-01 Astex Therapeutics Limited Pharmaceutical combinations
US8916552B2 (en) 2006-10-12 2014-12-23 Astex Therapeutics Limited Pharmaceutical combinations
AU2008315048A1 (en) 2007-10-23 2009-04-30 Msd K.K. Pyridone-substituted-dihydropyrazolopyrimidinone derivative
PE20091101A1 (en) 2007-12-18 2009-07-26 Pharminox Ltd 3-SUBSTITUTED-4-OXO-3,4-DIHYDRO-IMIDAZO [5,1-d] [1,2,3,5-TETRACINE-8-CARBOXYL ACID AMIDES AND ITS USE
EP2367828B1 (en) * 2008-11-24 2014-06-11 Reliance Life Sciences Pvt., Ltd. Process for the preparation of tetrazine derivatives
EP2403339B1 (en) 2009-03-06 2017-01-18 Merck Sharp & Dohme Corp. Combination cancer therapy with an akt inhibitor and other anticancer agents
JP2012530775A (en) 2009-06-23 2012-12-06 ファーミノックス リミテッド 3-substituted-8-substituted-3H-imidazo [5,1-d] [1,2,3,5-tetrazin-4-one compounds and uses thereof
RU2462466C1 (en) * 2011-06-24 2012-09-27 Автономная Некоммерческая Организация "Научно-Исследовательский Центр Биотехнологии Антибиотиков И Других Биологически Активных Веществ "Биоан" Substituted azolo[1,2,4,5]tetrazines - inhibitors of antibacterial serine-threonine protein kinases
US20140271657A1 (en) 2011-10-12 2014-09-18 Children's Medical Center Corporation Combinatorial compositions and methods of treating hemoglobinopathies
EA201892075A1 (en) 2016-03-15 2019-04-30 Оризон Дженомикс, С.А. COMBINATION OF LSD1 INHIBITORS FOR USE FOR THE TREATMENT OF SOLID TUMORS
KR101847342B1 (en) * 2017-05-08 2018-04-11 (주)센텍코리아 Wearable body fat burning measurement device

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2932305A1 (en) * 1979-08-09 1981-02-26 Basf Ag Pyrrolo-, pyrazolo-, imidazo- and thiazolo-tetrazin-4-one derivs. - prepd. from amino-azole cpds. by diazotisation and reaction with isocyanate

Also Published As

Publication number Publication date
KR890000094B1 (en) 1989-03-07
DE19975037I2 (en) 2001-06-13
FI822921L (en) 1983-02-25
DK161147C (en) 1991-11-18
NL192739B (en) 1997-09-01
ES515176A0 (en) 1983-11-01
FI73434B (en) 1987-06-30
OA07174A (en) 1984-04-30
FR2511679A1 (en) 1983-02-25
UA5971A1 (en) 1994-12-29
DK377882A (en) 1983-02-25
BE894175A (en) 1983-02-23
LV5511A3 (en) 1994-03-10
JPH045029B2 (en) 1992-01-30
NL990010I1 (en) 1999-07-01
LT2436B (en) 1994-02-15
GR76863B (en) 1984-09-04
GB2104522A (en) 1983-03-09
NZ201668A (en) 1985-08-16
LV5621A3 (en) 1994-05-10
IT1152505B (en) 1987-01-07
IL66606A (en) 1987-07-31
DK161147B (en) 1991-06-03
ATA319182A (en) 1985-09-15
AU571430B2 (en) 1988-04-21
HU186107B (en) 1985-06-28
FI822921A0 (en) 1982-08-23
IT8222938A0 (en) 1982-08-23
DE3231255A1 (en) 1983-03-03
JPS5843975A (en) 1983-03-14
SE8204817L (en) 1983-02-25
NL192739C (en) 1998-01-06
CH655114A5 (en) 1986-03-27
ES8400438A1 (en) 1983-11-01
IE822026L (en) 1983-02-24
LU84347A1 (en) 1983-06-07
IE53408B1 (en) 1988-11-09
IL66606A0 (en) 1982-12-31
SE448543B (en) 1987-03-02
SE8204817D0 (en) 1982-08-23
GEP19960641B (en) 1996-11-15
DE3231255C2 (en) 1992-02-27
FR2511679B1 (en) 1985-02-01
NL8203286A (en) 1983-03-16
CA1197247A (en) 1985-11-26
SU1447284A3 (en) 1988-12-23
GB2104522B (en) 1985-06-12
KR840001175A (en) 1984-03-28
FI73434C (en) 1987-10-09
ZA826120B (en) 1983-07-27
AT380256B (en) 1986-05-12
AU8749382A (en) 1983-03-03

Similar Documents

Publication Publication Date Title
MX9203176A (en) 1,2,4-TRIAZOLONES SUBSTITUTED WITH PHENOXYETHYLL AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
NL192201B (en) Pharmacologically active phenylaminoalkylcyclobutane compounds and compositions containing these compounds.
IT8220611A0 (en) TOPICAL PHARMACEUTICAL COMPOSITIONS.
NL990010I2 (en) Ä3HÜ-imidazo-Ä5,1-dÜ-1,2,3,5-tetrazine-4-one derivatives and pharmaceutical compositions containing these derivatives.
IL66501A0 (en) Benzazepine-2-one derivatives,their manufacture and pharmaceutical compositions containing them
DE3267350D1 (en) 5,6,7-trinor-4,8-inter-m-phenylene pgi derivatives and pharmaceutical compositions containing them
IT1190824B (en) PHARMACEUTICAL COMPOSITION CONTAINING 24.25-DIHYDROXICOLECALCIFEROL AS ACTIVE INGREDIENT
IT7926662A0 (en) PHARMACEUTICAL COMPOSITION CONTAINING 3,4-DI-HYDRO-3-OXO-2-QUINOXALINES.
NZ185539A (en) Cis-4a-aryl-2-substituted-2,3,4,4a,5,6,7,7a-octa hydro-1h-2-pyrindines and pharmaceutical compositions
BE896711A (en) ANTI-ULCER PHARMACEUTICAL COMPOSITIONS.
DE3268487D1 (en) 2,3,4-trinor-m-inter-phenylene-prostaglandin derivatives, their preparation and pharmaceutical compositions
NZ184185A (en) 3,5,5-trimethylhexanoyl-ferrocene and pharmaceutical compositions
NL193317B (en) 1,8-Diacyloxy-10-acylantrones and cosmetic and pharmaceutical compositions containing them.
IT1186667B (en) 2,1,3-BENZOTHIADIAZOLS AND 2,1,3-BENZOXYADIAZOLS, THEIR PREPARATION AND THEIR APPLICATION AS MEDICATIONS
IL64932A0 (en) Pharmaceutical compositions containing certain 2-azolylmethyl 1,3-dioxolane and-dioxane derivatives
IT1206513B (en) PHARMACEUTICAL COMPOSITIONS ANTIBIOTIC-IMMUNOSTIMULANT ADAPTITY.
NL193821B (en) Pharmaceutical preparation.
NL190120C (en) 2,3-DIHYDRO-4H-1-BENZOPYRAN-4-ON-0-CARBAMOYLOXIMES AND THEIR PHARMACEUTICAL PREPARATION THEREOF.
NL174646C (en) 6,7-DIMETHOXY-4-AMINO-2-PIPERIDINOQUINAZOLINS AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
NZ185996A (en) 6, 7-methylene-3-oxo-d-homo-17a-pregna-4, 16-dienes and pharmaceutical compositions
IT8124920A0 (en) NEW PHARMACEUTICAL COMPOSITION.
IT8247665A0 (en) PHARMACEUTICAL COMPOSITION BASED ON TIACROMANE DERIVATIVES, WITH HEMOBIOLOGICAL PROPERTIES
DK264082A (en) 1,2,3,4,4A, 9B-HEXAHYDRO-4A-PIPERAZINYLMETHYL-4-DIBENZOFURANON DIBENZOFURANODE DERIVATIVES
FI823694A0 (en) N-SUBSTITUTES ERGOLIN- OCH 9,10, -DIDEHYDRO-ERGOLIN-8-CARBOXIAMID-8-AMINOMETHYL DERIVATIVES, DERAS FRAMSTAELLNING OCH DERAS PHARMACEUTICAL COMPOSITION
NL8403873A (en) PYRAZOLOPYRIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITIONS, CONTAINING THESE DERIVATIVES.